biotinylated tnf Search Results


93
R&D Systems biotinylated tnf
Biotinylated Tnf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Recombinant+Human+TNF-alpha%2C+Biotinylated+Protein/pmc12663160-260-21-24
Average 93 stars, based on 1 article reviews
biotinylated tnf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
R&D Systems anti tnf β
Anti Tnf β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Human+Lymphotoxin-alpha%2FTNF-beta+Biotinylated+Antibody/pmc02972714-122-97-100
Average 92 stars, based on 1 article reviews
anti tnf β - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
R&D Systems anti tnf
Anti Tnf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Mouse+TNF-alpha+Biotinylated+Antibody/bio_rxiv__2025__07__27__666827-323-18-20
Average 94 stars, based on 1 article reviews
anti tnf - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
ACROBiosystems biotinylated human tnfα
A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with <t>human</t> <t>TNFα</t> and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).
Biotinylated Human Tnfα, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Biotinylated+Human+TNF-alpha+Protein%2C+His%2CAvitag/bio_rxiv__2025__04__20__649139-266-15-18
Average 95 stars, based on 1 article reviews
biotinylated human tnfα - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
R&D Systems goat anti human tnf α
A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with <t>human</t> <t>TNFα</t> and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).
Goat Anti Human Tnf α, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Human+TNF-alpha+Biotinylated+Antibody/pmc02829210-147-3-6
Average 94 stars, based on 1 article reviews
goat anti human tnf α - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
R&D Systems biotinylated goat anti human tnf α
A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with <t>human</t> <t>TNFα</t> and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).
Biotinylated Goat Anti Human Tnf α, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Human+TNF-alpha+Biotinylated+Antibody/pm20156030-32-8-16
Average 94 stars, based on 1 article reviews
biotinylated goat anti human tnf α - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems human tnf ri tnfrsf1a biotinylated antibody
A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with <t>human</t> <t>TNFα</t> and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).
Human Tnf Ri Tnfrsf1a Biotinylated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Human+TNF+RI%2FTNFRSF1A+Biotinylated+Antibody/pmc12696803-274-137-144
Average 93 stars, based on 1 article reviews
human tnf ri tnfrsf1a biotinylated antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
R&D Systems biotinylated anti mouse tnf α
A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with <t>human</t> <t>TNFα</t> and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).
Biotinylated Anti Mouse Tnf α, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Mouse+TNF-alpha+Biotinylated+Antibody/pmc05579272-157-8-13
Average 91 stars, based on 1 article reviews
biotinylated anti mouse tnf α - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
R&D Systems biotinylated polyclonal anti mouse tnfα detection antibody
A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with <t>human</t> <t>TNFα</t> and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).
Biotinylated Polyclonal Anti Mouse Tnfα Detection Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Mouse+TNF+RII%2FTNFRSF1B+Biotinylated+Antibody/pm27531183-271-12-18
Average 90 stars, based on 1 article reviews
biotinylated polyclonal anti mouse tnfα detection antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
R&D Systems human type 1 tnf receptor
Figure 1 (a) <t>Ad-TNFR–Ig-transduced</t> human islets express and secrete TNFR–Ig. In all, 200–300 human islets were infected with either 5 104 or 1 106 PFU of Ad-TNFR–Ig or Ad-eGFP. After 2 days, supernatant from the cultures was collected and the islets were lysed. ELISA was performed on the supernatants and the lysates were probed with an antibody specific for the ligand-binding domain of the human type 1 TNF receptor in a Western blot. The inset to the figure shows TNFR–Ig immunoreactivity in ELISA and the legend to the blot is as follows: lane 1: untransduced human islet supernatant; lane 2: untransduced human islet lysate; lane 3: Ad-eGFP-transduced human islets (5 MOI); lane 4: Ad-eGFP-transduced human islets (100 MOI); lane 5: Ad- TNFR–Ig-transduced human islets (5 MOI); lane 6: Ad-TNFR–Ig-transduced human islets (100 MOI). The migration of the TNFR–Ig protein is indicated by the arrow and the molecular weight markers are also shown. (b) Adenoviral gene transfer of Ad-TNFR–Ig to human islets prevents cytokine-induced impairment of glucose-stimulated insulin release. In all, 200–300 islets were infected with 1 106 PFU of Ad-TNFR–Ig and exposed to 75–100 U TNFa/ 50 U of IL-1b for a period between 18 and 24 h. Islets were then subjected to a dynamic 60-min glucose perifusion assay. Insulin was measured in the supernatant by ELISA and insulin output per islet culture was corrected by DNA content in the cluster using the fluorescent CyQuant reagent. At the top of the graph, we show the major time points of the perifusion. The x-axis represents the glucose concentration in the medium during the assay for the given time intervals (illustrated at the top of the graph) and the y-axis represents the insulin secreted at specific time points corrected by the DNA content of the insulin-secreting islets. These perifusion data are representative of three independently performed assays using islets from different cadaveric donors.
Human Type 1 Tnf Receptor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Human+TNF+RI%2FTNFRSF1A+Biotinylated+Antibody/pm15229635-134-19-26
Average 93 stars, based on 1 article reviews
human type 1 tnf receptor - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems human tnf α
Figure 1 (a) <t>Ad-TNFR–Ig-transduced</t> human islets express and secrete TNFR–Ig. In all, 200–300 human islets were infected with either 5 104 or 1 106 PFU of Ad-TNFR–Ig or Ad-eGFP. After 2 days, supernatant from the cultures was collected and the islets were lysed. ELISA was performed on the supernatants and the lysates were probed with an antibody specific for the ligand-binding domain of the human type 1 TNF receptor in a Western blot. The inset to the figure shows TNFR–Ig immunoreactivity in ELISA and the legend to the blot is as follows: lane 1: untransduced human islet supernatant; lane 2: untransduced human islet lysate; lane 3: Ad-eGFP-transduced human islets (5 MOI); lane 4: Ad-eGFP-transduced human islets (100 MOI); lane 5: Ad- TNFR–Ig-transduced human islets (5 MOI); lane 6: Ad-TNFR–Ig-transduced human islets (100 MOI). The migration of the TNFR–Ig protein is indicated by the arrow and the molecular weight markers are also shown. (b) Adenoviral gene transfer of Ad-TNFR–Ig to human islets prevents cytokine-induced impairment of glucose-stimulated insulin release. In all, 200–300 islets were infected with 1 106 PFU of Ad-TNFR–Ig and exposed to 75–100 U TNFa/ 50 U of IL-1b for a period between 18 and 24 h. Islets were then subjected to a dynamic 60-min glucose perifusion assay. Insulin was measured in the supernatant by ELISA and insulin output per islet culture was corrected by DNA content in the cluster using the fluorescent CyQuant reagent. At the top of the graph, we show the major time points of the perifusion. The x-axis represents the glucose concentration in the medium during the assay for the given time intervals (illustrated at the top of the graph) and the y-axis represents the insulin secreted at specific time points corrected by the DNA content of the insulin-secreting islets. These perifusion data are representative of three independently performed assays using islets from different cadaveric donors.
Human Tnf α, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Recombinant+Human+TNF-alpha%2C+Biotinylated+Protein/pmc05465082-298-18-24
Average 93 stars, based on 1 article reviews
human tnf α - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
R&D Systems goat anti mouse tnfri antibody
Figure 1. Screening of excreted molecules in nephritic urine using commercial protein arrays. A, Representative array profile depicting the reactivity patterns of urine from 4 strains of mice, 14 days after challenge with antiglomerular antibodies, using the accelerated model, as described previously (3). Black dots indicate the presence of particular proteins. The 4 black dots at the top left represent the positive control, and the 4 blank spots immediately below represent the negative control. Colored circles represent the 4 molecules that were reproducibly elevated in urine from DBA/1 and 129/Sv mice, but not in urine from BALB/c and B6 mice, following nephrotoxic insult. Each array is representative of 2 independent experiments, each of which was conducted using 5 urine samples pooled from each strain of mice. B, Relative abundance of the different proteins, as gauged by measur- ing the image intensity using ImageJ software. The profile shown is representative of 2 independent experiments. These results were further validated using a second approach, enzyme-linked immunosor- bent assay, as detailed in the text and in Figure 2. VCAM-1 vascular cell adhesion molecule 1; <t>TNFRI</t> tumor necrosis factor receptor I; AU arbitrary unit.
Goat Anti Mouse Tnfri Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+tnf/Mouse+TNF+RI%2FTNFRSF1A+Biotinylated+Antibody/pm17328072-84-28-32
Average 90 stars, based on 1 article reviews
goat anti mouse tnfri antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with human TNFα and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).

Journal: bioRxiv

Article Title: NewroBus for the brain: humanized TfR1-targeting nanobodies with high BBB permeability and cargo transport capacity

doi: 10.1101/2025.04.20.649139

Figure Lengend Snippet: A ) Schematic representation of the 16 humanized and optimized TNFI–TfR1b heterodimers. B ) Flow cytometry analysis in HEK293 cells stably expressing human TfR1, comparing the binding of heterodimers to that of their parental humanized TfR1b-Nbs. C ) Dose-response apoptosis inhibition curves in WEHI-13VAR cells treated with human TNFα and 2-fold serial dilutions of TNFI–TfR1b heterodimers (100,000 to 12.21 pM). Apoptosis was measured using a fluorogenic caspase-3/7 activation assay. The IC₅₀ values of the heterodimers were comparable to those of the parental humanized nanobodies TNFI-α (IC₅₀ = 48.84 pM, range: 42.11–56.56) and TNFI-β (IC₅₀ = 64.31 pM, range: 57.17–72.31).

Article Snippet: The same procedure was used with the following modifications: plates were coated with 0.2 µg/mL biotinylated human TNFα (Acro Biosystems, TNA-H82E3-25ug) instead of TfR1.

Techniques: Flow Cytometry, Stable Transfection, Expressing, Binding Assay, Inhibition, Activation Assay

Figure 1 (a) Ad-TNFR–Ig-transduced human islets express and secrete TNFR–Ig. In all, 200–300 human islets were infected with either 5 104 or 1 106 PFU of Ad-TNFR–Ig or Ad-eGFP. After 2 days, supernatant from the cultures was collected and the islets were lysed. ELISA was performed on the supernatants and the lysates were probed with an antibody specific for the ligand-binding domain of the human type 1 TNF receptor in a Western blot. The inset to the figure shows TNFR–Ig immunoreactivity in ELISA and the legend to the blot is as follows: lane 1: untransduced human islet supernatant; lane 2: untransduced human islet lysate; lane 3: Ad-eGFP-transduced human islets (5 MOI); lane 4: Ad-eGFP-transduced human islets (100 MOI); lane 5: Ad- TNFR–Ig-transduced human islets (5 MOI); lane 6: Ad-TNFR–Ig-transduced human islets (100 MOI). The migration of the TNFR–Ig protein is indicated by the arrow and the molecular weight markers are also shown. (b) Adenoviral gene transfer of Ad-TNFR–Ig to human islets prevents cytokine-induced impairment of glucose-stimulated insulin release. In all, 200–300 islets were infected with 1 106 PFU of Ad-TNFR–Ig and exposed to 75–100 U TNFa/ 50 U of IL-1b for a period between 18 and 24 h. Islets were then subjected to a dynamic 60-min glucose perifusion assay. Insulin was measured in the supernatant by ELISA and insulin output per islet culture was corrected by DNA content in the cluster using the fluorescent CyQuant reagent. At the top of the graph, we show the major time points of the perifusion. The x-axis represents the glucose concentration in the medium during the assay for the given time intervals (illustrated at the top of the graph) and the y-axis represents the insulin secreted at specific time points corrected by the DNA content of the insulin-secreting islets. These perifusion data are representative of three independently performed assays using islets from different cadaveric donors.

Journal: Gene therapy

Article Title: Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.

doi: 10.1038/sj.gt.3302320

Figure Lengend Snippet: Figure 1 (a) Ad-TNFR–Ig-transduced human islets express and secrete TNFR–Ig. In all, 200–300 human islets were infected with either 5 104 or 1 106 PFU of Ad-TNFR–Ig or Ad-eGFP. After 2 days, supernatant from the cultures was collected and the islets were lysed. ELISA was performed on the supernatants and the lysates were probed with an antibody specific for the ligand-binding domain of the human type 1 TNF receptor in a Western blot. The inset to the figure shows TNFR–Ig immunoreactivity in ELISA and the legend to the blot is as follows: lane 1: untransduced human islet supernatant; lane 2: untransduced human islet lysate; lane 3: Ad-eGFP-transduced human islets (5 MOI); lane 4: Ad-eGFP-transduced human islets (100 MOI); lane 5: Ad- TNFR–Ig-transduced human islets (5 MOI); lane 6: Ad-TNFR–Ig-transduced human islets (100 MOI). The migration of the TNFR–Ig protein is indicated by the arrow and the molecular weight markers are also shown. (b) Adenoviral gene transfer of Ad-TNFR–Ig to human islets prevents cytokine-induced impairment of glucose-stimulated insulin release. In all, 200–300 islets were infected with 1 106 PFU of Ad-TNFR–Ig and exposed to 75–100 U TNFa/ 50 U of IL-1b for a period between 18 and 24 h. Islets were then subjected to a dynamic 60-min glucose perifusion assay. Insulin was measured in the supernatant by ELISA and insulin output per islet culture was corrected by DNA content in the cluster using the fluorescent CyQuant reagent. At the top of the graph, we show the major time points of the perifusion. The x-axis represents the glucose concentration in the medium during the assay for the given time intervals (illustrated at the top of the graph) and the y-axis represents the insulin secreted at specific time points corrected by the DNA content of the insulin-secreting islets. These perifusion data are representative of three independently performed assays using islets from different cadaveric donors.

Article Snippet: Following washing in PBST, the membrane was incubated with an antibody specific for the extracellular ligand-binding domain of the human type 1 TNF receptor (clone BAF225, R&D Systems, Indianapolis, IN, USA) at 0.2 mg/ml in 5% BSA.

Techniques: Infection, Enzyme-linked Immunosorbent Assay, Ligand Binding Assay, Western Blot, Migration, Molecular Weight, CyQUANT Assay, Concentration Assay

Figure 3 (a) Ad-TNFR–Ig-transduced murine islets survive longer in allogeneic recipients. Groups of 400 Balb/c islets were transduced with 1 106 PFU Ad-TNFR–Ig in culture and then transplanted underneath the kidney capsules of C57BL/6 recipients previously rendered diabetic by streptozotocin. Normoglycemia was present for the longest time in recipients of Ad-TNFR–Ig-transduced islets. The error bars represent the standard error of the mean. Po0.01, Ad-TNFR–Ig-transduced islet recipients versus untransduced islet recipients; Kaplan–Meier log-rank test. (b) Normoglycemia in blood correlates with the diabetes-free state in Ad-TNFR–Ig-transduced islet transplant recipients. Blood glucose remains within the normal range in allogeneic recipients of Ad-TNFR–Ig- transduced islets over the study period. The error bars indicate the standard error of the mean.

Journal: Gene therapy

Article Title: Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.

doi: 10.1038/sj.gt.3302320

Figure Lengend Snippet: Figure 3 (a) Ad-TNFR–Ig-transduced murine islets survive longer in allogeneic recipients. Groups of 400 Balb/c islets were transduced with 1 106 PFU Ad-TNFR–Ig in culture and then transplanted underneath the kidney capsules of C57BL/6 recipients previously rendered diabetic by streptozotocin. Normoglycemia was present for the longest time in recipients of Ad-TNFR–Ig-transduced islets. The error bars represent the standard error of the mean. Po0.01, Ad-TNFR–Ig-transduced islet recipients versus untransduced islet recipients; Kaplan–Meier log-rank test. (b) Normoglycemia in blood correlates with the diabetes-free state in Ad-TNFR–Ig-transduced islet transplant recipients. Blood glucose remains within the normal range in allogeneic recipients of Ad-TNFR–Ig- transduced islets over the study period. The error bars indicate the standard error of the mean.

Article Snippet: Following washing in PBST, the membrane was incubated with an antibody specific for the extracellular ligand-binding domain of the human type 1 TNF receptor (clone BAF225, R&D Systems, Indianapolis, IN, USA) at 0.2 mg/ml in 5% BSA.

Techniques: Transduction, Capsules

Figure 2 Infection of human islets in culture with Ad-TNFR–Ig prevented cytokine-induced apoptosis activation. In all, 200–300 islets were infected with 1 106 PFU Ad-eGFP or Ad-TNFR–Ig, and then treated with either 75–100 U TNFa alone or with a combination of TNFa and 50 U of IL-1b for a period between 18 and 24 h. Apoptosis was measured by Annexin V/ propidium iodide staining of single cells by FACS analysis. The data are representative of results from three independent experiments using islets obtained from three different donors.

Journal: Gene therapy

Article Title: Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.

doi: 10.1038/sj.gt.3302320

Figure Lengend Snippet: Figure 2 Infection of human islets in culture with Ad-TNFR–Ig prevented cytokine-induced apoptosis activation. In all, 200–300 islets were infected with 1 106 PFU Ad-eGFP or Ad-TNFR–Ig, and then treated with either 75–100 U TNFa alone or with a combination of TNFa and 50 U of IL-1b for a period between 18 and 24 h. Apoptosis was measured by Annexin V/ propidium iodide staining of single cells by FACS analysis. The data are representative of results from three independent experiments using islets obtained from three different donors.

Article Snippet: Following washing in PBST, the membrane was incubated with an antibody specific for the extracellular ligand-binding domain of the human type 1 TNF receptor (clone BAF225, R&D Systems, Indianapolis, IN, USA) at 0.2 mg/ml in 5% BSA.

Techniques: Infection, Activation Assay, Staining

Figure 1. Screening of excreted molecules in nephritic urine using commercial protein arrays. A, Representative array profile depicting the reactivity patterns of urine from 4 strains of mice, 14 days after challenge with antiglomerular antibodies, using the accelerated model, as described previously (3). Black dots indicate the presence of particular proteins. The 4 black dots at the top left represent the positive control, and the 4 blank spots immediately below represent the negative control. Colored circles represent the 4 molecules that were reproducibly elevated in urine from DBA/1 and 129/Sv mice, but not in urine from BALB/c and B6 mice, following nephrotoxic insult. Each array is representative of 2 independent experiments, each of which was conducted using 5 urine samples pooled from each strain of mice. B, Relative abundance of the different proteins, as gauged by measur- ing the image intensity using ImageJ software. The profile shown is representative of 2 independent experiments. These results were further validated using a second approach, enzyme-linked immunosor- bent assay, as detailed in the text and in Figure 2. VCAM-1 vascular cell adhesion molecule 1; TNFRI tumor necrosis factor receptor I; AU arbitrary unit.

Journal: Arthritis and rheumatism

Article Title: Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance.

doi: 10.1002/art.22556

Figure Lengend Snippet: Figure 1. Screening of excreted molecules in nephritic urine using commercial protein arrays. A, Representative array profile depicting the reactivity patterns of urine from 4 strains of mice, 14 days after challenge with antiglomerular antibodies, using the accelerated model, as described previously (3). Black dots indicate the presence of particular proteins. The 4 black dots at the top left represent the positive control, and the 4 blank spots immediately below represent the negative control. Colored circles represent the 4 molecules that were reproducibly elevated in urine from DBA/1 and 129/Sv mice, but not in urine from BALB/c and B6 mice, following nephrotoxic insult. Each array is representative of 2 independent experiments, each of which was conducted using 5 urine samples pooled from each strain of mice. B, Relative abundance of the different proteins, as gauged by measur- ing the image intensity using ImageJ software. The profile shown is representative of 2 independent experiments. These results were further validated using a second approach, enzyme-linked immunosor- bent assay, as detailed in the text and in Figure 2. VCAM-1 vascular cell adhesion molecule 1; TNFRI tumor necrosis factor receptor I; AU arbitrary unit.

Article Snippet: Kidney sections obtained from 129/Sv mice 14 days after anti-GBM antibody challenge were stained with the following primary antibodies: goat anti-mouse CXCL16 antibody (R&D Systems; catalog no. AF503), goat anti-mouse TNFRI antibody (R&D Systems; catalog no. BAF425), goat anti-mouse VCAM-1 antibody (R&D Systems; catalog no. BAF643), or goat anti-mouse P-selectin antibody (Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. SC-6941) or the isotype control antibodies.

Techniques: Positive Control, Negative Control, Software

Figure 2. Urine levels of VCAM-1, CXCL16, P-selectin, and TNFRI, by enzyme-linked immunosorbent assay (ELISA). DBA/1 and 129/Sv mice develop renal disease that is severe compared with that in B6 and BALB/c mice, when challenged with antiglomerular antibodies. In this model of severe disease, 24-hour urine levels of protein and albumin peak on day 14 and tend to remain high until day 21 (top row). Typically, healthy B6 mice do not excrete 1 mg of protein per 24-hour period. The 24-hour urine levels of VCAM-1, CXCL16, TNFRI, and P-selectin followed a very similar time course, as depicted in the second through fifth rows. Each plot was derived by monitoring 5–6 mice per strain through day 21. Within each row, the data from the 4 strains are plotted using the same y-axis scale, in order to highlight the differences between strains. Day 14 and day 21 levels of all 4 molecules were significantly higher in DBA/1 and 129/Sv mice compared with the 2 control strains, BALB/c and B6. Broken lines connect the mean values. P 0.05; P 0.01; P 0.001 by Student’s t-test (or Mann-Whitney nonparametric test for non-normally distributed data), day 7, day 14, and day 21 versus day 0. NS not significant (see Figure 1 for other definitions).

Journal: Arthritis and rheumatism

Article Title: Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance.

doi: 10.1002/art.22556

Figure Lengend Snippet: Figure 2. Urine levels of VCAM-1, CXCL16, P-selectin, and TNFRI, by enzyme-linked immunosorbent assay (ELISA). DBA/1 and 129/Sv mice develop renal disease that is severe compared with that in B6 and BALB/c mice, when challenged with antiglomerular antibodies. In this model of severe disease, 24-hour urine levels of protein and albumin peak on day 14 and tend to remain high until day 21 (top row). Typically, healthy B6 mice do not excrete 1 mg of protein per 24-hour period. The 24-hour urine levels of VCAM-1, CXCL16, TNFRI, and P-selectin followed a very similar time course, as depicted in the second through fifth rows. Each plot was derived by monitoring 5–6 mice per strain through day 21. Within each row, the data from the 4 strains are plotted using the same y-axis scale, in order to highlight the differences between strains. Day 14 and day 21 levels of all 4 molecules were significantly higher in DBA/1 and 129/Sv mice compared with the 2 control strains, BALB/c and B6. Broken lines connect the mean values. P 0.05; P 0.01; P 0.001 by Student’s t-test (or Mann-Whitney nonparametric test for non-normally distributed data), day 7, day 14, and day 21 versus day 0. NS not significant (see Figure 1 for other definitions).

Article Snippet: Kidney sections obtained from 129/Sv mice 14 days after anti-GBM antibody challenge were stained with the following primary antibodies: goat anti-mouse CXCL16 antibody (R&D Systems; catalog no. AF503), goat anti-mouse TNFRI antibody (R&D Systems; catalog no. BAF425), goat anti-mouse VCAM-1 antibody (R&D Systems; catalog no. BAF643), or goat anti-mouse P-selectin antibody (Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. SC-6941) or the isotype control antibodies.

Techniques: Enzyme-linked Immunosorbent Assay, Derivative Assay, Control, MANN-WHITNEY

Figure 3. Serum levels of VCAM-1, CXCL16, P-selectin, and TNFRI during anti–glomerular basement membrane (anti-GBM) antibody–induced nephritis. Serum levels of CXCL16, P-selectin, TNFRI, and VCAM-1 were assayed in the same sets of mice (n 5–6 mice per strain) described in Figure 2, on days 0, 7, 14, and 21 after the anti-GBM antibody insult. Broken lines connect the mean values. P 0.05; P 0.01; P 0.001 by Student’s t-test (or Mann-Whitney nonparametric test for non-normally distributed data), day 7, day 14, and day 21 versus day 0. NS not significant (see Figure 1 for other definitions).

Journal: Arthritis and rheumatism

Article Title: Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance.

doi: 10.1002/art.22556

Figure Lengend Snippet: Figure 3. Serum levels of VCAM-1, CXCL16, P-selectin, and TNFRI during anti–glomerular basement membrane (anti-GBM) antibody–induced nephritis. Serum levels of CXCL16, P-selectin, TNFRI, and VCAM-1 were assayed in the same sets of mice (n 5–6 mice per strain) described in Figure 2, on days 0, 7, 14, and 21 after the anti-GBM antibody insult. Broken lines connect the mean values. P 0.05; P 0.01; P 0.001 by Student’s t-test (or Mann-Whitney nonparametric test for non-normally distributed data), day 7, day 14, and day 21 versus day 0. NS not significant (see Figure 1 for other definitions).

Article Snippet: Kidney sections obtained from 129/Sv mice 14 days after anti-GBM antibody challenge were stained with the following primary antibodies: goat anti-mouse CXCL16 antibody (R&D Systems; catalog no. AF503), goat anti-mouse TNFRI antibody (R&D Systems; catalog no. BAF425), goat anti-mouse VCAM-1 antibody (R&D Systems; catalog no. BAF643), or goat anti-mouse P-selectin antibody (Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. SC-6941) or the isotype control antibodies.

Techniques: Membrane, MANN-WHITNEY

Figure 4. Expression of CXCL16, P-selectin, TNFRI, and VCAM-1 within nephritic kidneys. RNA from the renal cortex of 129/Sv mice (n 5) with anti–glomerular basement membrane antibody–induced nephritis was isolated on days 0, 7, and 15, and mRNA levels of the 4 molecules were assayed by real-time polymerase chain reaction. The fold change is with respect to mRNA levels on day 0 and was calculated after normalization against GAPDH message, as detailed elsewhere (27). Values are the mean and SD. P 0.05; P 0.001 by Student’s t-test (or Mann-Whitney nonparametric test for non- normally distributed data), day 7 and day 15 versus day 0. NS not significant (see Figure 1 for other definitions).

Journal: Arthritis and rheumatism

Article Title: Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance.

doi: 10.1002/art.22556

Figure Lengend Snippet: Figure 4. Expression of CXCL16, P-selectin, TNFRI, and VCAM-1 within nephritic kidneys. RNA from the renal cortex of 129/Sv mice (n 5) with anti–glomerular basement membrane antibody–induced nephritis was isolated on days 0, 7, and 15, and mRNA levels of the 4 molecules were assayed by real-time polymerase chain reaction. The fold change is with respect to mRNA levels on day 0 and was calculated after normalization against GAPDH message, as detailed elsewhere (27). Values are the mean and SD. P 0.05; P 0.001 by Student’s t-test (or Mann-Whitney nonparametric test for non- normally distributed data), day 7 and day 15 versus day 0. NS not significant (see Figure 1 for other definitions).

Article Snippet: Kidney sections obtained from 129/Sv mice 14 days after anti-GBM antibody challenge were stained with the following primary antibodies: goat anti-mouse CXCL16 antibody (R&D Systems; catalog no. AF503), goat anti-mouse TNFRI antibody (R&D Systems; catalog no. BAF425), goat anti-mouse VCAM-1 antibody (R&D Systems; catalog no. BAF643), or goat anti-mouse P-selectin antibody (Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. SC-6941) or the isotype control antibodies.

Techniques: Expressing, Membrane, Isolation, Real-time Polymerase Chain Reaction, MANN-WHITNEY

Figure 5. Immunohistochemical localization of CXCL16, P-selectin, tumor necrosis factor receptor I (TNFRI), and vascular cell adhesion molecule 1 (VCAM-1) within diseased kidneys. Formalin-fixed kidney sections from 129/Sv mice, obtained on day 0 or day 15 following the anti–glomerular basement membrane antibody challenge, were stained with antibodies to P-selectin, CXCL16, TNFRI, or VCAM-1, or with the secondary control antibody. Results are representative of 3–5 independent kidney sections.

Journal: Arthritis and rheumatism

Article Title: Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance.

doi: 10.1002/art.22556

Figure Lengend Snippet: Figure 5. Immunohistochemical localization of CXCL16, P-selectin, tumor necrosis factor receptor I (TNFRI), and vascular cell adhesion molecule 1 (VCAM-1) within diseased kidneys. Formalin-fixed kidney sections from 129/Sv mice, obtained on day 0 or day 15 following the anti–glomerular basement membrane antibody challenge, were stained with antibodies to P-selectin, CXCL16, TNFRI, or VCAM-1, or with the secondary control antibody. Results are representative of 3–5 independent kidney sections.

Article Snippet: Kidney sections obtained from 129/Sv mice 14 days after anti-GBM antibody challenge were stained with the following primary antibodies: goat anti-mouse CXCL16 antibody (R&D Systems; catalog no. AF503), goat anti-mouse TNFRI antibody (R&D Systems; catalog no. BAF425), goat anti-mouse VCAM-1 antibody (R&D Systems; catalog no. BAF643), or goat anti-mouse P-selectin antibody (Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. SC-6941) or the isotype control antibodies.

Techniques: Immunohistochemical staining, Membrane, Staining, Control